Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure

Journal of the American College of Cardiology

Volumn 39, Issue 5, 2002, Pages 798-803

  Silver, Marc A ^a   Horton, Darlene P ^b   Ghali, Jalal K ^c   Elkayam, Uri ^d  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b SCIOS INC   (United States)

^c Cardiac Centers of Louisiana   (United States)

^d LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; GLYCERYL TRINITRATE; INOTROPIC AGENT; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM; VASOACTIVE AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; DOSE RESPONSE; FEMALE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; TACHYCARDIA;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037028855     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01818-6     Document Type: Article

References (10)

1. Cost-effectiveness analysis in clinical practice: The case of heart failure
2. Economic impact of heart failure in the United States: Time for a different approach
3. Effect of oral milrinone on mortality in severe chronic heart failure: The PROMISE Study Research Group
4. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the Flosequinan-ACE inhibitor Trial (FACET)
5. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study
6. Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
7. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
8. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial
9. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure
10. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries